Clinical experiences with a new non-steroid antirheumatic agent
Carcassi, A.
Minerva Medica 64(45): 2361-2364
1973
ISSN/ISBN: 0026-4806 PMID: 4733891 Document Number: 61093
Document emailed within 1 workday
Related Documents
Giudice, G.; Cardona, S.; Serra, G.C. 1973: Preliminary clinical experiences with a non-depolarizing curarizing agent with steroid structure: pancuronium bromide Minerva Anestesiologica 39(10): 433-442Hiebsch, H.J.; Thümmler, W. 1983: Efficacy and tolerance of isoxicam in outpatients with gonarthrosis and coxarthrosis. Comparison with another non-steroid antirheumatic agent Die Medizinische Welt 34(45): 1286-1289
Lonauer, G.; Wagner, H.; Boerngen, U.; Goebel, K.M. 1981: Lonazolac-Ca-a non-steroidal antirheumatic agent. Long-term clinical study in chronic polyarthritis Zeitschrift für Rheumatologie 40(4): 161-164
Varma, Y.S.; Sharma, P.L. 1971: Clinical experience with pancuronium bromide (NA97): a new steroid neuromuscular blocking agent Indian Journal of Medical Research 59(1): 69-75
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907
Rechziegler, H. 1984: Non-steroid antirheumatic agents. Criteria for a rational selection Fortschritte der Medizin 102(17): 497-502
Rifat, K.; Stainier, H.; Gemperle, M.; Szappanyos, G.; Hemmer, M.; Weiss, V. 1975: Clinical investigations of the steroid anaesthetic agent CT-1341 (Althesin) (Cardiovascular and respiratory effects) Der Anaesthesist 24(1): 6-12
Ferrari, M.; Bigi, N. 1970: Clinical experiences with a new anti-arrhythmic agent: disopyramide (Rhythmodan) Minerva Medica 61(71): 3728-3733
Weber, H. 1971: Clinical experiences with a new spasmoanalgesic agent in double-blind test Zeitschrift für Allgemeinmedizin 47(6): 299-300
Sieberová, R. 1971: Clinical experiences with administration of oral antidiabetic agent Buformin Casopis Lekaru Ceskych 110(18): 420-421
2004: Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection MMW Fortschritte der Medizin 146(22): 48
Neviani, V.; Tosi, P.; Prampolini, M.L. 1976: 1st experiences with the clinical use of a new beta-blocking agent (tolamolol) in some heart diseases La Clinica Terapeutica 77(5): 451-458
Podzich, M. 1982: Percutaneous therapy of soft tissue rheumatic diseases. Clinical trials of the non-steroid anti-phlogistic agent Rheumon gel ZFA. Zeitschrift für Allgemeinmedizin 58(16): 921-924
Pfeifer, S.; Bornschein, I.; Gehrke, A. 1977: Biotransformation of 2-phenyl-4-/beta-dimethylamino-ethyl/-6-methyl-2,3-dihydro-1,4-benzoxazine-3-one ("AR 17 O48) a potential antirheumatic agent Die Pharmazie 32(10): 587-592
Wied, G.L.; Davis, M.E. 1959: A new orally effective progestational agent: increased effectiveness in the human of a progestational agent by attaching a methyl-group at carbon position six of the steroid ring Obstetrics and Gynecology 14: 305-308
Wolfe, F.; Rehman, Q.; Lane, N.E.; Kremer, J. 2001: Starting a disease modifying antirheumatic drug or a biologic agent in rheumatoid arthritis: standards of practice for RA treatment Journal of Rheumatology 28(7): 1704-1711
Branco do Amaral, A. 1982: Short-term and long-term open evaluation of the efficacy and tolerance of proglumetacin, a new antirheumatic agent Pharmatherapeutica 3(3): 174-179
Otani, Y.; Kawagoe, T. 1968: Contraceptive effects of a jelly with a surface active agent as the basic and ingredient clinical experiences with a new contraceptive drug, Penicap Sanfujinka no Jissai. Practice of Gynecology and Obstetrics 17(7): 657-659
Maeda, A.; Jin, T.; Satone, T.; Oyama, C. 1973: Effect of CT-1341, a new steroid anesthetic agent on adrenocortical function in man Masui. Japanese Journal of Anesthesiology 22(1): 59-65
Chieli, T.; Fregnan, G.B.; Frigerio, L.; Vidali, M. 1976: Toxicity and collateral pharmacological effects of a 3: a new non-steroid anti-inflammatory agent Bollettino Chimico Farmaceutico 115(1): 41-57